The largest database of trusted experimental protocols

6 protocols using mda mb231 mda 231

1

Breast Cancer Cell-Endothelial Cell Co-culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Breast cancer cell lines MDA-MB231 (MDA-231), MCF-7, and HUVEC were purchased from American Type Culture Collection (ATCC, USA). GFP+ECs (ECs) were developed as described previously [21 (link)]. Human recombinant Jagged1 and TGFβ1 were obtained from R&D Systems and PeproTech, respectively. Υ-secretase inhibitors (GSI) and SB-431542 were purchased from Sigma (USA). Breast cancer cells (BCCs) were grown in DMEM/High glucose (HyClone, USA) supplemented with 10% FBS, L-glutamine, non-essential amino acids (NEAA), and penicillin/streptomycin in a humidified incubator with 5% CO2. ECs were grown in M199 growth medium (Gibco, USA) supplemented with 20% FBS, 20 ng/ml β-Endothelial Cell Growth Factor (βECG), 20 units/ml heparin and penicillin/streptomycin. The co-cultures were prepared by mixing one part BCCs with 10 parts GFP+ECs (1:10 ratio) and cells were grown in 1:1 ratio of DMEM/High and M199 media in the absence of serum and growth factors (complete starvation). Co-cultivation of BCCs and ECs was performed over 3–5 days under adherent condition.
+ Open protocol
+ Expand
2

Breast Cancer Cell Lines Culturing Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDA-MB-157 (MDA-157), MDA-MB-231(MDA-231) and MDA-MB-468 (MDA-468), MCF10A, and HCC1806 cells were purchased from the American Type Culture Collection (ATCC #’s HTB-24, HTB-26, HTB-132, CRL-10317, and CRL-2335, respectively) within the last 12 months and passaged < 15 times for all experiments. Cells were tested biweekly during experiments for mycoplasma contamination using the Lonza MycoAlert (Lonza #LT07-318). HCC1806 cells were grown in RPMI 1640 Medium (Life Technologies #11875093) and supplemented with 10% Fetal Bovine Serum (FBS, Atlantic Biologicals Premium Select). MDA-157, MDA-231, MDA-468, and MCF10A cells were grown in DMEM High Glucose + GlutaMAX (Life Technologies #10566016) and supplemented with 1% sodium pyruvate (Life Technologies #11360070) and 10% FBS. Cells were maintained in a humidified 37°C incubator with 5% carbon dioxide.
+ Open protocol
+ Expand
3

Authentication and Culturing of Human Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human breast carcinoma cell lines, MDA-MB-468 (MDA468), HCC1806, HCC1569, HCC1500, MCF7, T47D, ZR75–1, and MDA-MB231 (MDA231), were purchased from American Type Culture Collection. MCF7, MDA468 and MDA231 were cultured in DMEM medium supplemented with 10% FBS, streptomycin (100 mg/ml) and penicillin (100 units/ml). HCC1806, HCC1569, HCC1500, T47D and ZR75–1 were cultured in RPMI medium supplemented with 10%FBS, streptomycin (100mg/ml) and penicillin (100units/ml). All cells were grown at 37 °C in a 5% CO2 atmosphere. All cells are tested negative of Mycoplasma by PCR (ATCC Universal Mycoplasma Detection Kit), and they were used between passages 15 and 45. All cell lines were obtained between 2010 and 2019, and they were authenticated by qRT-PCR analysis for the expression of 20 signature genes.
+ Open protocol
+ Expand
4

Genetic Modification of Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human breast cancer cell lines MDA-MB-231 (MDA231) and MCF7 were purchased from American Type Culture Collection (ATCC). Genetically modified breast cancer cell lines (MDA.Gluc and MCF7.Gluc) were generated by transfection with Gaussian-luc cDNA construct to promote the constitutive expression of Gaussia luciferase in neomycin resistant cells. The stable Rab27a knockdown cell line (MDA.Rab27a.shRNA) was established by Rab27a shRNA lentivirus (sc-41834-v, Santa Cruz Biotechnology, Bio-Strategy Pty Limited, Australia) transduction using Polybrene® (sc-134220, Santa Cruz Biotechnology, Bio-Strategy Pty Limited, Australia) in puromycin resistant cells. Transient Rab27a knockdown in MDA231 cells was established by Rab27a siRNA (sc-41834, Santa Cruz Biotechnology, Bio-Strategy Pty Limited, Australia) transfection using Lipofectamine™ RNAiMAX Transfection Reagent (Invitrogen, Thermo Fisher Scientific, Australia PTY LTD). Successful knockdown was confirmed by western blot. All cell lines were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (1965118, Gibco, Thermo Fisher Scientific, Australia PTY LTD) supplemented with 10% fetal calf serum (FCS) (HyCloneTM, GE Healthcare Life Sciences, USA), 10 µg/mL penicillin and 100 µg/mL streptomycin (Invitrogen, Thermo Fisher Scientific, Australia PTY LTD). Cell cultures were grown at 37 °C with 10% CO2 in a humidified atmosphere.
+ Open protocol
+ Expand
5

Culture and Maintenance of Common Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human breast cancer cell lines MDA-MB-231 (MDA-231), BT549 and human embryonic kidney 293T (HEK-293T) were purchased from the American Type Culture Collection (ATCC, Manassas, VA, United States). MDA-231 and BT549 cells were grown in RPMI-1640 medium (Hyclone, South Logan, UT, United States); HEK-293T cells were cultured in DMEM medium, and all media were supplemented with 10% fetal bovine serum (HyClone) under standard culture conditions (5% CO2 at 37 °C).
+ Open protocol
+ Expand
6

Characterization of Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human embryonic kidney 293 T cell line, human breast cancer cell lines MDA-MB-231 (MDA231), T47D and MCF7 were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). IMP1 knockdown T47D cells, MDA231/IMP1-GFP and MDA231/GFP cell lines were previously generated [36 (link), 37 (link)]. UCA1 overexpression and knockdown MDA231 and T47D stable cell lines were established by stable infection of lentivirus expressing UCA1 or UCA1-short hairpin RNA (shRNA). Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Thermo Fisher Scientific, USA) supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and 100 μg/ml streptomycin at 37 °C in a humid environment with 5% CO2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!